A 5-Question Quiz on Sarcoma

Article

Do you know the most common site of metastasis in soft-tissue sarcoma? Or which histologies are most sensitive to chemotherapy? Answer these questions and more.

Question 1:

Answer and Question 2 on Next Page »

The correct answer is D. Rhabdomyosarcoma

Question 2:

Answer and Question 3 on Next Page »

The correct answer is B. Preoperative radiotherapy may be associated with better local control and increased risk of acute wound complications

Question 3:

Answer and Question 4 on Next Page »

The correct answer is C. 45 to 55 years

Question 4:

Answer and Question 5 on Next Page »

The correct answer is B. Lymphadenectomy is required given the high likelihood of nodal metastasis

Question 5:

Answer on Next Page »

The correct answer is A. Lung

 

Recent Videos
4 experts in this video
4 experts in this video
Ongoing research suggests environmental exposures and the role of microbiomes may influence bladder cancer development and response to treatment.
Providing easier access to ancillary services for patients with PDAC who live farther away from the treatment center may help them complete the treatment regimen.
Future research will aim to assess the efficacy of PIPAC-MMC plus systemic therapy vs systemic therapy alone in patients with peritoneal tumors.
Although small incision surgery may serve as a conduit to deliver PIPAC-MMC, it may confer benefits in the staging and treatment of peritoneal tumors.
Related Content
All patients identified as low risk for sentinel lymph node positivity with the DecisionDx-Melanoma test had recurrence-free status after 3 years.

DecisionDx-Melanoma Test Accurately Identifies Low-Risk SLN Positivity

Roman Fabbricatore
April 4th 2025
Article

All patients identified as low risk for sentinel lymph node positivity with the DecisionDx-Melanoma test had recurrence-free status after 3 years.

Adjuvant Therapy and Post-Surgical Management Options for Kidney Cancer

Adjuvant Therapy and Post-Surgical Management Options for Kidney Cancer

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD
April 1st 2025
Podcast

A recent Oncology Decoded podcast focuses on adjuvant therapy like pembrolizumab and optimal post-surgical care for patients with kidney cancer.

A futility analysis showed that ociperlimab was unlikely to reach the primary end point of overall survival as part of the phase 3 AdvanTIG-302 trial.

Developers Terminate Clinical Program for Ociperlimab in Lung Cancer

Russ Conroy
April 3rd 2025
Article

A futility analysis showed that ociperlimab was unlikely to reach the primary end point of overall survival as part of the phase 3 AdvanTIG-302 trial.

The “inescapability” of climate hazards may necessitate prioritization of research to improve outcomes among vulnerable populations who require treatment.

Improving NSCLC Surgery Recovery After Climate Disaster Exposure

Leticia Nogueira, PhD, MPH
March 31st 2025
Podcast

The “inescapability” of climate hazards may necessitate prioritization of research to improve outcomes among vulnerable populations who require treatment.

Guideline Update Supports Laser Therapy for Brain Tumors After SRS

Guideline Update Supports Laser Therapy for Brain Tumors After SRS

Tim Cortese
April 2nd 2025
Article

The REMASTer trial found that laser interstitial thermal therapy was equivalent to open craniotomy regarding OS and PFS data in progressive metastatic brain tumors.

A Staged Approach Offers Benefits Without OS Detriment in Appendix Cancers

A Staged Approach Offers Benefits Without OS Detriment in Appendix Cancers

Tim Cortese
April 2nd 2025
Article

Muhammad Talwa Waheed, MD, found that resection after appendectomy should be prioritized in the treatment of patients with appendiceal cancer.